BioWorld

Oct. 31, 2007

View Archived Issues

Amgen Spinout Relypsa Starts Business With $33M Series A

If the story of newly established Relypsa Inc., a company created to develop nonabsorbed polymeric drugs for renal and cardiovascular diseases, sounds more than a little familiar, that's probably because it is. (BioWorld Today) Read More

India's Glenmark in $350M Deal With Lilly For Pain Compound

Read More

Acceleron Series C Gets $31M For Bone, Muscle Growth Bids

Read More

Genoptix IPO Soars 56 percent; RXi Files For Independence

Read More

Neurobiological Offering Nets $56 Million For Viprinex Trials

Read More

Other News To Note

Read More

U.S. Patent Disclosures

Read More

Clinic Roundup

Read More